Frankfort Approves $1.3 Million in Bills, Including Annual Insurance Payment
The Frankfort Village Board authorized over $1.3 million in payments at its meeting Monday, with nearly half of the total amount covering the village’s annual insurance premiums.
Trustees unanimously approved the schedule of bills totaling $1,308,224.37. Trustee Adam Borrelli explained the composition of the substantial figure, highlighting the largest single expenditure.
“About half of that is our payment to SWARM, which is our basically our insurance payment for general liability, property, and workman’s comp,” Borrelli said. “And that total is $645,490, and again that payment is for the entire year.”
The remainder of the approved bills covered operational costs across several village funds. According to the meeting’s financial documents, disbursements included $784,236.59 from the General Corporate Fund, $236,909.37 from the Capital Development Fund, $238,533.06 for Sewer and Water Operations and Maintenance, and $48,545.35 from the Sewer and Water Extension Fund.
The approval of the bills was part of the board’s unanimous consent agenda, which includes routine items that are passed in a single vote without separate discussion.
Latest News Stories
JJC Board Meeting Halted by Lack of Quorum; New Student Trustee Sworn In
JJC Entrepreneur and Business Center Celebrates $800,000 Federal Grant, Client Successes
Chicago mayor to push for local funding, keeping Bears
Senate Republicans unveil $72 billion budget package to fund ICE, CBP
Illinois AI regulations have mild industry support, could draw federal ire
DOJ files complaint to block Minnesota climate lawsuit
Hegseth: Ceasefire holds despite Iranian aggression
Illinois Quick Hits: Mayors to visit capitol urge protection of local funding
Despite tax revolt, Lower Merion keeps administrator pay high
Supreme Court allows Louisiana to immediately move on drawing new map
After Fifth Circuit ruling on TX border security law, ACLU sues to stop it from going into effect
Colorado legislators back psychedelic drug research